KAITLYN BUCHANAN: Open Payments
NPI 1699318139 · SAVANNAH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$8,533 in 222 payments from 24 companies in 2025. Trend: 2023 $4,132 · 2024 $4,437 · 2025 $8,533
Food & beverage: $5,488Consulting: $2,520Travel & lodging: $456Education: $69
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 19 | $3,458 |
| AstraZeneca Pharmaceuticals LP | 24 | $1,038 |
| Actelion Pharmaceuticals US, Inc. | 20 | $661 |
| GlaxoSmithKline, LLC. | 32 | $482 |
| Inspire Medical Systems, Inc. | 8 | $457 |
| Verona Pharma, Inc. | 17 | $388 |
| Regeneron Healthcare Solutions, Inc. | 23 | $364 |
| Axsome Therapeutics, Inc. | 23 | $308 |
| Amgen Inc. | 9 | $199 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $181 |
Products named: DUPIXENT, INSPIRE, UPTRAVI, Ohtuvayre, NUCALA, TEZSPIRE, Sunosi, AIRSUPRA.
Industry payments across GA — which companies pay providers there.
